Andrew R. Allen
Chief Medical Officer, Exec VP, PHARMION CORP.
Companies
- Cullinan OncologyBoard member Aug 8, 2025 to now1
- Adaptimmune (United Kingdom)Board member Jun 1, 2023 to now2
- Gritstone bio, Inc.Board member Sep 27, 2018 to Jun 26, 20243
- Gritstone bio, Inc.Chief executive officer Sep 27, 2018 to Jun 26, 20243
- Gritstone bio, Inc.President Sep 27, 2018 to Jun 26, 20243
- TCR2 THERAPEUTICS INC.Board member Feb 13, 2019 to Jun 1, 20234
- Sierra Oncology, Inc.Board member Oct 25, 2017 to Jul 1, 20225
- Epizyme, Inc.Board member Jun 11, 2014 to Jun 15, 20216
- Clovis OncologySee General Remarks Nov 15, 2011 to Mar 4, 20157
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Sierra Oncology, Inc.0 shares8Jul 1, 2022
- Gritstone bio, Inc.1,310,360 shares9Jun 26, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 24, 2024Gift 325,000 shares of Gritstone bio, Inc.9
- Jun 24, 2024Gift 325,000 shares of Gritstone bio, Inc.9
- May 16, 2024Sold 24,263 shares at $0.75 of Gritstone bio, Inc.10
- May 15, 2024Granted 47,873 shares of Gritstone bio, Inc.10
- Feb 1, 2024Granted 105,000 shares of Gritstone bio, Inc.11
- Feb 2, 2023Granted 738,550 shares of Gritstone bio, Inc.12
- Jul 1, 2022Returned to company 1,650 shares at $55.00 of Sierra Oncology, Inc.8
- Jan 31, 2022Granted 70,000 shares of Gritstone bio, Inc.13
- Jan 7, 2021Granted 48,200 shares of Gritstone bio, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCullinan Oncology, Board member
- 2
- 3SEC EDGARGritstone bio, Inc., Board member
- 4SEC EDGARTCR2 THERAPEUTICS INC., Board member
- 5SEC EDGARSierra Oncology, Inc., Board member
- 6SEC EDGAREpizyme, Inc., Board member
- 7SEC EDGARClovis Oncology, See General Remarks
- 8
- 9
- 10SEC EDGARForm 4 filed May 17, 2024
- 11SEC EDGARForm 4 filed Feb 5, 2024
- 12SEC EDGARForm 4 filed Feb 6, 2023
- 13SEC EDGARForm 4 filed Apr 20, 2022
- 14SEC EDGARForm 4 filed Nov 19, 2021